These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1509638)

  • 1. Elevated levels of serum aldolase A in patients with renal cell carcinoma.
    Takashi M; Zhu Y; Nakano Y; Miyake K; Kato K
    Urol Res; 1992; 20(4):307-11. PubMed ID: 1509638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of serum gamma-enolase and aldolase A in combination as markers for renal cell carcinoma.
    Takashi M; Sakata T; Kato K
    Jpn J Cancer Res; 1993 Mar; 84(3):304-9. PubMed ID: 8486529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunochemical and immunohistochemical study of aldolase isozymes in renal cell carcinoma.
    Zhu YY; Takashi M; Miyake K; Kato K
    J Urol; 1991 Aug; 146(2):469-72. PubMed ID: 1856954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum creatine kinase B subunit in patients with renal cell carcinoma.
    Takashi M; Zhu Y; Hasegawa S; Kato K
    Urol Int; 1992; 48(2):144-8. PubMed ID: 1585508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum iron as a tumor marker in renal cell carcinoma.
    Yu CC; Chen KK; Chen MT; Huang JK; Lin AT; Lee YH; Chang LS
    Eur Urol; 1991; 19(1):54-8. PubMed ID: 2007419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor M2 pyruvate kinase in plasma of patients with urological tumors.
    Roigas J; Schulze G; Raytarowski S; Jung K; Schnorr D; Loening SA
    Tumour Biol; 2001; 22(5):282-5. PubMed ID: 11553857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of aldolase C isozyme in renal cell carcinoma.
    Takashi M; Haimoto H; Koshikawa T; Kato K
    Am J Clin Pathol; 1990 May; 93(5):631-6. PubMed ID: 2183586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma.
    Takashi M; Haimoto H; Tanaka J; Murase T; Kato K
    J Urol; 1989 Apr; 141(4):830-4. PubMed ID: 2648028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.
    Kim KH; Lee HH; Yoon YE; Na JC; Kim KS; Han WK
    Investig Clin Urol; 2019 Nov; 60(6):425-431. PubMed ID: 31692952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
    Wechsel HW; Petri E; Bichler KH; Feil G
    Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.
    Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R
    Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aldolase].
    Taguchi K; Takagi Y
    Rinsho Byori; 2001 Nov; Suppl 116():117-24. PubMed ID: 11797371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced cytosolic carboxypeptidase 6 (CCP6) level leads to accumulation of serum polyglutamylated DNAJC7 protein: A potential biomarker for renal cell carcinoma early detection.
    Li C; Wang J; Hao J; Dong B; Li Y; Zhu X; Ding J; Ren S; Zhao H; Wu S; Tian Y; Wang GQ
    Oncotarget; 2016 Apr; 7(16):22385-96. PubMed ID: 26993597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume.
    Kirkali Z; Güzelsoy M; Mungan MU; Kirkali G; Yörükoglu K
    Urol Int; 1999; 62(1):21-5. PubMed ID: 10436426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue polypeptide-specific antigen in renal cell carcinoma.
    Höbarth K; Hallas A; Kramer G; Aulitzky W; Gomahr A; Steiner G; Marberger M
    Eur Urol; 1996; 30(1):89-95. PubMed ID: 8854074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume.
    Partin AW; Criley SR; Steiner MS; Hsieh K; Simons JW; Lumadue J; Carter HB; Marshall FF
    Urology; 1995 Feb; 45(2):211-7. PubMed ID: 7855968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum tissue factor as a biomarker for renal clear cell carcinoma.
    Silva DD; Noronha JAP; Pinheiro da Costa BE; Zandona PCE; Carvalhal GF
    Int Braz J Urol; 2018; 44(1):38-44. PubMed ID: 28727370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
    Jou YC; Tsai YS; Hsieh HY; Chen SY; Tsai HT; Chen KJ; Wang ST; Shiau AL; Wu CL; Tzai TS
    Urol Oncol; 2013 Nov; 31(8):1806-11. PubMed ID: 22609059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker.
    Ljungberg B; Rasmuson T; Grankvist K
    Eur Urol; 1992; 21(2):160-3. PubMed ID: 1499617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?
    Gross AJ; Michl UH; Bornhöft G; Dieckmann KP
    Eur Urol; 1993; 24(3):397-9. PubMed ID: 8262110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.